{
    "eid": "2-s2.0-85085155211",
    "title": "Generation and characterization of HLA-universal platelets derived from induced pluripotent stem cells",
    "cover-date": "2020-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Phatchara Norbnop",
        "Praewphan Ingrungruanglert",
        "Nipan Israsena",
        "Kanya Suphapeetiporn",
        "Vorasuk Shotelersuk"
    ],
    "citedby-count": 29,
    "ref-count": 34,
    "ref-list": [
        "Platelets and the immune continuum",
        "New strategies for the optimal use of platelet transfusions",
        "Why has demand for platelet components increased? A review",
        "Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME)",
        "Refractoriness to platelet transfusion",
        "Reactions Induced by Platelet Transfusions",
        "HLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention and management",
        "Platelet refractoriness\u2013practical approaches and ongoing dilemmas in patient management",
        "Persistence of recipient human leucocyte antigen (HLA) antibodies and production of donor HLA antibodies following reduced intensity allogeneic haematopoietic stem cell transplantation",
        "Platelet transfusion refractoriness",
        "Rituximab, plasma exchange and intravenous immunoglobulins as a new treatment strategy for severe HLA alloimmune platelet refractoriness",
        "HLA engineering of human pluripotent stem cells",
        "Generating hypoimmunogenic human embryonic stem cells by the disruption of beta 2-microglobulin",
        "Generation of HLA-deficient platelets from hematopoietic progenitor cells",
        "HLA-universal platelet transfusions prevent platelet refractoriness in a mouse model",
        "Generation of HLA-universal iPSCs-derived megakaryocytes and platelets for survival under refractoriness conditions",
        "Scalable generation of universal platelets from human induced pluripotent stem cells",
        "Induction of pluripotent stem cells from adult human fibroblasts by defined factors",
        "CRISPR-Cas systems for editing, regulating and targeting genomes",
        "RNA-guided genetic silencing systems in bacteria and archaea",
        "A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity",
        "Multiplex genome engineering using CRISPR/Cas systems",
        "Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity",
        "Paired D10A Cas9 nickases are sometimes more efficient than individual nucleases for gene disruption",
        "Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements",
        "CRISPR/Cas9 Genome-Editing System in Human Stem Cells: Current Status and Future Prospects",
        "HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells",
        "Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice",
        "NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs",
        "HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications",
        "Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity",
        "Platelets impair natural killer cell reactivity and function in endometriosis through multiple mechanisms",
        "Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production",
        "Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn Academic Advancement",
        "Chulalongkorn University",
        "National Science and Technology Development Agency"
    ]
}